These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of cardiac multidetector computed tomography in the exclusion of ischemic etiology in heart failure patients. Sousa PA; Bettencourt N; Dias Ferreira N; Carvalho M; Leite D; Ferreira W; de Jesus I; Gama V Rev Port Cardiol; 2014 Oct; 33(10):629-36. PubMed ID: 25281557 [TBL] [Abstract][Full Text] [Related]
27. Sex Differences in the Coronary System. Taqueti VR Adv Exp Med Biol; 2018; 1065():257-278. PubMed ID: 30051390 [TBL] [Abstract][Full Text] [Related]
29. The alternative "ischemic" cascade in coronary microvascular disease. Picano E Cardiologia; 1999 Sep; 44(9):791-5. PubMed ID: 10609387 [TBL] [Abstract][Full Text] [Related]
30. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries. Montone RA; Niccoli G; Russo M; Giaccari M; Del Buono MG; Meucci MC; Gurgoglione F; Vergallo R; D'Amario D; Buffon A; Leone AM; Burzotta F; Aurigemma C; Trani C; Liuzzo G; Lanza GA; Crea F Clin Res Cardiol; 2020 Apr; 109(4):435-443. PubMed ID: 31270616 [TBL] [Abstract][Full Text] [Related]
31. Myocardial ischemia is not always due to epicardial atheromatous disease. Richard Conti C Clin Cardiol; 2011 Jan; 34(1):8-9. PubMed ID: 21259271 [TBL] [Abstract][Full Text] [Related]
32. [Coronary microvascular dysfunction: mechanisms and clinical outcome]. Indolfi C; Porto I; Muscoli S; Fedele F; Mancone M G Ital Cardiol (Rome); 2022 Jun; 23(6):397-407. PubMed ID: 35674027 [TBL] [Abstract][Full Text] [Related]
33. Inflammation in Coronary Microvascular Dysfunction. Sagris M; Theofilis P; Antonopoulos AS; Oikonomou E; Paschaliori C; Galiatsatos N; Tsioufis K; Tousoulis D Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948272 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary Stenosis. Hong D; Shin D; Lee SH; Joh HS; Choi KH; Kim HK; Ha SJ; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM Circ Cardiovasc Interv; 2023 Mar; 16(3):e012621. PubMed ID: 36846961 [TBL] [Abstract][Full Text] [Related]
35. Coronary Microvascular Dysfunction in Patients with Congenital Heart Disease. Vanreusel I; Segers VFM; Craenenbroeck EV; Berendoncks AV Curr Cardiol Rev; 2023; 19(4):e190123212886. PubMed ID: 36658708 [TBL] [Abstract][Full Text] [Related]
36. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF). Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458 [TBL] [Abstract][Full Text] [Related]
37. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. Del Buono MG; Montone RA; Camilli M; Carbone S; Narula J; Lavie CJ; Niccoli G; Crea F J Am Coll Cardiol; 2021 Sep; 78(13):1352-1371. PubMed ID: 34556322 [TBL] [Abstract][Full Text] [Related]
38. Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease. Mehta PK; Quesada O; Al-Badri A; Fleg JL; Volgman AS; Pepine CJ; Merz CNB; Shaw LJ Int J Cardiol; 2022 Feb; 348():1-8. PubMed ID: 34902504 [TBL] [Abstract][Full Text] [Related]